Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes

Circulation Research

Volumn 86, Issue 2, 2000, Pages 139-143

  Napoleone, Emanuela ^a   Di Santo, Angelomaria ^a   Camera, Marina ^b   Tremoli, Elena ^b   Lorenzet, Roberto ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Angiotensin; Coagulation; Leukocyte

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTOXIN; FOSINOPRIL; IDRAPRIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; THROMBOPLASTIN;

ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSLOCATION; HEART INFARCTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOGENESIS;

EID: 0033960710     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.2.139     Document Type: Article

References (14)

1. Haber E. The role of renin in normal and pathological cardiovascular homeostasis. Circulation. 1976;54:849-861.
2. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992; 340:1173-1178.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115-1122.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
5. Powell JS, Clozel J-P, Muller RKM, Khun H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.
6. 2+ mobilization and protein kinase C activation. J Biol Chem. 1989;264:526-530.
7. van Leeuwen RT, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation. 1994;90:362-368.
8. Schindler R, Dinarello CA, Koch K-M. Angiotensin-converting enzyme inhibitors suppress synthesis of tumor necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine. 1995;7:526-533.
9. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 1996;94:2756-2767.
10. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15(suppl 5):S65-S72.
11. Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:1-8.
12. Semeraro N, Biondi A, Lorenzet R, Locati D, Mantovani A, Donati MB. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology. 1983;50:529-535.
13. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest. 1983;71:1893-1896.
14. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A. 1994;91:8767-8771.